Valneva Invest Information

Companies
Valneva Seeks to Extend Use of Chikungunya Vaccine with Label Extension Submissions Sep 19, 2024
Pharmaceuticals
Valneva Seeks to Extend IXCHIQ® Usage Through EMA and Health Canada Applications Sep 18, 2024
Companies
Valneva's Innovative IXCHIQ® Becomes the First Chikungunya Vaccine Authorized in Europe Jul 1, 2024
Companies
Valneva SE to Engage in Investor Conferences Highlighting June 2024 Agenda Jun 4, 2024
Companies
Valneva Showcases Innovative Chikungunya Vaccine at World Vaccine Congress Mar 21, 2024
Companies
Valneva SE Secures Extension of Interest-Only Period with Key Investors Mar 19, 2024
Stocks
Valneva SE's VALN Chikungunya Vaccine Receives FDA Approval, Company's Stock Rises Nov 10, 2023